SeaStar Medical Holding Corp — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 78/100
What the filing says
On June 25, 2026, SeaStar Medical's Compensation Committee approved retention bonuses for CEO Eric Schlorff ($200,000) and Kevin Chung ($140,000), payable in three equal installments through March 1, 2027, conditional on continued employment. Each executive may also receive RSU grants equal to 25% of bonus payments, vesting in three tranches. Total cash commitment is $340,000; RSU value contingent on future share prices.
Why this rating
Retention bonuses totaling $340K equal ~4.7% of $7.3M market cap—material relative to company size. Signals leadership stability concerns but does not change business trajectory.
Extracted items
- 5.02 exec change
- 9.01 exhibits
View original filing on SEC.gov ↗
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.